Gestational diabetes & diabetes in pregnancy
Healthcare professionals' views about how pregnant women can benefit from using a closed‐loop system: Qualitative study
Authors' conclusion
Healthcare professionals recommended that closed-loop systems be offered to all pregnant women with type 1 diabetes in the future. Presenting closed-loop systems to pregnant women and healthcare teams as one pillar of a three-party collaboration may help promote optimal use.
Study context
- Population
- Healthcare professionals who supported pregnant women with T1D using the CamAPS FX closed-loop system during the AiDAPT trial
- Participants
- 19 healthcare professionals
- Outcome
- HCPs' views on how, and why, pregnant women benefitted from using closed-loop (descriptive and analytical themes relevant to clinical practice)
Methodological detailsnested in AiDAPT trial
- Nested in AiDAPT trial
Main finding
As reported in the abstract
Themes from HCP interviews
- Clinical and quality-of-life benefits of closed-loop in pregnancy, some attributed to the CGM component
- Closed-loop not a panacea; maximum benefit needed effective collaboration between HCPs, the woman and the closed-loop
- Optimal performance required women to interact with the system sufficiently but not excessively, which some women found challenging
- Women still benefitted even where this balance was not achieved
- Difficult to predict how specific women would engage with the technology
- HCPs favoured an inclusive approach to closed-loop rollout in routine clinical care
Original publication
Healthcare professionals' views about how pregnant women can benefit from using a closed‐loop system: Qualitative study. Diabet Med. Published 7 March 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →